Kate L. Weeks has not added Biography.
If you are Kate L. Weeks and would like to personalize this page please email our Author Liaison for assistance.
β-Adrenergic Stimulation Induces Histone Deacetylase 5 (HDAC5) Nuclear Accumulation in Cardiomyocytes by B55α-PP2A-Mediated Dephosphorylation.
Journal of the American Heart Association Mar, 2017 | Pubmed ID: 28343149
Phosphoinositide 3-kinase (p110α) gene delivery limits diabetes-induced cardiac NADPH oxidase and cardiomyopathy in a mouse model with established diastolic dysfunction.
Clinical science (London, England : 1979) Jun, 2017 | Pubmed ID: 28487469
The IGF1-PI3K-Akt Signaling Pathway in Mediating Exercise-Induced Cardiac Hypertrophy and Protection.
Advances in experimental medicine and biology , 2017 | Pubmed ID: 29098623
Understanding Key Mechanisms of Exercise-Induced Cardiac Protection to Mitigate Disease: Current Knowledge and Emerging Concepts.
Physiological reviews 01, 2018 | Pubmed ID: 29351515
Gene delivery of medium chain acyl-coenzyme A dehydrogenase induces physiological cardiac hypertrophy and protects against pathological remodelling.
Clinical science (London, England : 1979) 02, 2018 | Pubmed ID: 29358507
Divergent Effects of PKC (Protein Kinase C) α in the Human and Animal Heart? Therapeutic Implications for PKC Inhibitors in Cardiac Patients.
Circulation. Genomic and precision medicine 03, 2018 | Pubmed ID: 29540469
Adeno-Associated Virus Gene Therapy: Translational Progress and Future Prospects in the Treatment of Heart Failure.
Heart, lung & circulation Nov, 2018 | Pubmed ID: 29703647
Nucleocytoplasmic shuttling: The ins and outs of quantitative imaging.
Clinical and experimental pharmacology & physiology 10, 2018 | Pubmed ID: 29772060
Role of type 2A phosphatase regulatory subunit B56α in regulating cardiac responses to β-adrenergic stimulation in vivo.
Cardiovascular research 03, 2019 | Pubmed ID: 30203051
HDAC inhibitors and cardioprotection: Homing in on a mechanism of action.
EBioMedicine Feb, 2019 | Pubmed ID: 30639419
Histone deacetylases in cardiovascular and metabolic diseases.
Journal of molecular and cellular cardiology 05, 2019 | Pubmed ID: 30978343
CORP: Practical tools for improving experimental design and reporting of laboratory studies of cardiovascular physiology and metabolism.
American journal of physiology. Heart and circulatory physiology 09, 2019 | Pubmed ID: 31347916
Gene therapy targeting cardiac phosphoinositide 3-kinase (p110α) attenuates cardiac remodeling in type 2 diabetes.
American journal of physiology. Heart and circulatory physiology 04, 2020 | Pubmed ID: 32142359
FoxO1 is required for physiological cardiac hypertrophy induced by exercise but not by constitutively active PI3K.
American journal of physiology. Heart and circulatory physiology 04, 2021 | Pubmed ID: 33577435
A protocol for rapid and parallel isolation of myocytes and non-myocytes from multiple mouse hearts.
STAR protocols Dec, 2021 | Pubmed ID: 34647038
Sebastian Bass-Stringer1,2,
Colleen J. Thomas2,3,
Clive N. May3,
Paul Gregorevic4,
Kate L. Weeks1,5,6,
Julie R. McMullen1,2,5,6,7
1, Baker Heart and Diabetes Institute,
2Department of Physiology, Anatomy and Microbiology, La Trobe University,
3Florey Institute of Neuroscience and Mental Health, University of Melbourne,
4Department of Physiology, Centre for Muscle Research (CMR), The University of Melbourne,
5Department of Diabetes, Central Clinical School, Monash University,
6Baker Department of Cardiometabolic Health, The University of Melbourne,
7Department of Physiology and Department of Medicine Alfred Hospital, Monash University
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved